Heda Ventures

Immunowake is a biotechnology company dedicated to developing innovative therapies for patients who do not respond to conventional immunotherapies. The company is focused on creating a universal cancer vaccine that aims to generate safer and more effective bi-specific antibodies. By activating the body’s immune system, particularly antigen-specific T-cells, Immunowake seeks to enhance the ability to identify and eliminate cancer cells. This approach not only aims to improve treatment outcomes for patients with limited options but also strives to reduce toxicity associated with existing therapies while maintaining significant anti-tumor efficacy.

LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Lianchuan Bio is provider of a genomics and precision medicine platform in China.

Citcon, founded in 2015 and headquartered in Silicon Valley, California, is a prominent payment technology company that enables global merchants to accept payments from a diverse range of mobile wallets. Its platform provides a secure and user-friendly payment infrastructure, facilitating transactions through web, mobile, and in-store channels. By utilizing a single API suite, Citcon offers businesses a comprehensive solution that encompasses payment processing, gateway services, reporting, and fund settlement. This approach allows merchants to cater to millions of mobile wallet consumers, enhancing the shopping experience with contactless payments that are both safer and more efficient. With regional offices across the U.S., Canada, Europe, and Asia, Citcon is well-positioned to support the growing demand for mobile payment solutions worldwide.

MuMec is a fabless startup building new wireless data transmission technology that uses drastically lower operating power. With these new wireless transceivers, the power budget is low enough to allow continuous operation of sensor node devices for years while using only scavenged or battery power.

Paragon Genomics, Inc. specializes in the development of polymerase chain reaction (PCR) reagents and components for molecular biology, focusing on targeted enrichment solutions for next-generation sequencing (NGS). Founded in 2015 and located in South San Francisco, California, the company offers its proprietary CleanPlex technology, which enables the creation of rapid and cost-effective targeted sequencing assays. Among its products are the CleanPlex targeted library kit, the CleanPlex OncoZoom Panel, and specific panels for the BRCA1, BRCA2, and TP53 genes, all designed to facilitate the amplification of DNA for NGS applications. Paragon Genomics' technology serves various sectors, including cancer research, liquid biopsy, biomarker discovery, genomics-guided breeding, companion diagnostics, and immunotherapy monitoring, providing accurate and sensitive solutions for diverse genomic needs.

Symic Biomedical, based in San Francisco, California, is a biotechnology company focused on developing matrix regulator therapeutics to address various health conditions. Founded in 2012, the company aims to treat osteoarthritis and cardiovascular diseases by targeting and inhibiting matrix degradation and pathological inflammatory responses associated with injury and disease. Its therapeutics are designed to bind to specific targets within the extracellular matrix, presenting potential applications in fibrosis, oncology, and central nervous system disorders. As a subsidiary of Symic Holdings, LLC, Symic Biomedical is dedicated to advancing therapeutic solutions that can improve patient outcomes in these critical areas of healthcare.

ScaleFlux, Inc. is a technology company specializing in data flow architecture and computational storage solutions designed to enhance data center and cloud infrastructure efficiency for demanding applications. Founded in 2014 and headquartered in San Jose, California, with additional offices in China, ScaleFlux focuses on delivering innovative technologies for data-driven applications. The company develops computational storage subsystems that combine advanced compute engines with solid-state storage, allowing clients to optimize their infrastructure for scalable and agile computing. By integrating storage intelligence, ScaleFlux enables organizations to improve performance and reduce costs in hybrid-cloud, on-premises, and cloud environments. The company is recognized for attracting top talent to create complex algorithms and efficient hardware solutions tailored to the evolving needs of the data-driven market.

Citcon, founded in 2015 and headquartered in Silicon Valley, California, is a prominent payment technology company that enables global merchants to accept payments from a diverse range of mobile wallets. Its platform provides a secure and user-friendly payment infrastructure, facilitating transactions through web, mobile, and in-store channels. By utilizing a single API suite, Citcon offers businesses a comprehensive solution that encompasses payment processing, gateway services, reporting, and fund settlement. This approach allows merchants to cater to millions of mobile wallet consumers, enhancing the shopping experience with contactless payments that are both safer and more efficient. With regional offices across the U.S., Canada, Europe, and Asia, Citcon is well-positioned to support the growing demand for mobile payment solutions worldwide.